Champions Oncology, Inc. (CSBR)

Listed in the US · Manufacturing · Biological products, (no diagnostic substances)

$4.81

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $4.81 on 29 Oct 2026. The share price traded between $4.59 and $8.31 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close $4.81

Low $4.59High $8.31

Market cap$67Mlast close × shares
Net profit−$0.94Mlast 12 months
Return on equity−29.9%year to Apr 2026
EBITDA margin0.4%year to Apr 2026
Net margin−2.0%year to Apr 2026
Dividend yieldnonelast 12 months

P/E isn't shown: the company made a loss over the last 12 months, and a loss has no P/E.

Price trend

Revenue and profit

RevenueNet profit$ million
-200204060
YearApr 2022Apr 2023Apr 2024Apr 2025Apr 2026
Revenue49.1153.8750.1656.9459.42
Net profit0.55-5.33-7.284.70-1.18
EBITDA margin4.3%-5.9%-10.9%10.8%0.4%

$ million. Over three years, compounded: revenue grew 3.3% a year.

Recent filings

Questions about Champions Oncology, Inc.

What is Champions Oncology, Inc.'s market value?

Champions Oncology, Inc.'s market value is $67M as of 29 Oct 2026 close: the last close times the shares in issue.

Go further with CSBR

Free to start: test a trading idea on CSBR's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Biological products, (no diagnostic substances)), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.